Machine Learning for Early Detection of Cognitive Decline in Parkinson's Disease Using Multimodal Biomarker and Clinical Data.

Mohammadi, Raziyeh; Ng, Samuel Y. E.; Tan, Jayne Y.; Ng, Adeline S. L.; Deng, Xiao; Choi, Xinyi; Heng, Dede L.; Neo, Shermyn; Xu, Zheyu; Tay, Kay-Yaw; Au, Wing-Lok; Tan, Eng-King; Tan, Louis C. S.; Steyerberg, Ewout W.; Greene, William; Saffari, Seyed Ehsan

Background: Parkinson's disease (PD) is the second most common neurodegenerative disease, primarily affecting the middle-aged to elderly population. Among its nonmotor symptoms, cognitive decline (CD) is a precursor to dementia and represents a critical target for early risk assessment and diagnosis. Accurate CD prediction is crucial for timely intervention and tailored management of at-risk patients. This study used machine learning (ML) techniques to predict the CD risk over five-year in early-stage PD. Methods: Data from the Early Parkinson's Disease Longitudinal Singapore (2014 to 2018) was used to predict CD defined as a one-unit annual decrease or a one-unit decline in Montreal Cognitive Assessment over two consecutive years. Four ML methods—AutoScore, Random Forest, K-Nearest Neighbors and Neural Network—were applied using baseline demographics, clinical assessments and blood biomarkers. Results: Variable selection identified key predictors of CD, including education year, diastolic lying blood pressure, diastolic standing blood pressure, systolic lying blood pressure, Hoehn and Yahr scale, body mass index, phosphorylated tau at threonine 181, total tau, Neurofilament light chain and suppression of tumorigenicity 2. Random Forest was the most effective, achieving an AUC of 0.93 (95% CI: 0.89, 0.97), using 10-fold cross-validation. Conclusions: Here, we demonstrate that ML-based models can identify early-stage PD patients at high risk for CD, supporting targeted interventions and improved PD management.

PARKINSON'S disease; MONTREAL Cognitive Assessment; DIASTOLIC blood pressure; SYSTOLIC blood pressure; SYMPTOMS

Biomedicines, 2024, Vol 12, Issue 12, p2758

2227-9059

Academic Journal

10.3390/biomedicines12122758